₩179,400.00
0.50%
Korea, Sep 18, 03:30 pm KST. Closed.
ISIN
KR7068270008
Symbol
068270
Index

Celltrion Stock price

₩179,400.00
-16,100.00 8.24% 1M
-20,123.81 10.09% 6M
+7,019.05 4.07% YTD
+19,592.46 12.26% 1Y
+53,083.55 42.02% 3Y
-43,396.35 19.48% 5Y
+105,371.86 142.34% 10Y
+175,922.91 5,059.49% 20Y
Korea, Closing price Fri, Sep 18 2026
-900.00 0.50%
ISIN
KR7068270008
Symbol
068270
Index
Industry

Is Celltrion a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,134 stocks worldwide.

Key metrics

Basic
Market capitalization
₩39.9t
Enterprise Value
₩42.4t
Net debt
-
Cash
-
Shares outstanding
-
Valuation (TTM | estimate)
P/E
26.2
P/S
8.2 | 7.2
EV/Sales
8.7 | 7.6
EV/FCF
77.3
P/B
2.3
Dividends
DPS
₩714.29
Yield 1Y | 5Y
0.4% | 0.3%
Growth 1Y | 5Y
4.0% | -
Payout 1Y | 3Y
38.1% | 21.5%
Increased
3 Years
Financials (TTM | estimate)
Revenue
₩4.9t | ₩5.6t
EBITDA
₩1.6t
EBIT
₩1.6t
Net Income
₩1.6t
Free Cash Flow
₩548.7b
Growth (TTM | estimate)
Revenue
30.6% | 33.8%
EBITDA
88.4%
EBIT
94.8%
Net Income
220.3%
Free Cash Flow
-1.9%
Margin
Gross
61.9%
EBITDA
33.2%
EBIT
31.7%
Net
32.2%
Free Cash Flow
11.2%
Financial Health
Equity Ratio
77.1%
Return on Equity
6.0%
ROCE
8.7%
ROIC
6.8%
Debt/Equity
-
More
EPS
₩6,850.3
FCF per Share
₩2,390.6
Short interest
-
Employees
3k
Rev per Employee
₩1.6b

Celltrion Stock Analysis

Unlock Scores for Free

Analyst Opinions

30 Analysts have issued a Celltrion forecast:

27x Buy
90%
3x Hold
10%

Analyst Opinions

30 Analysts have issued a Celltrion forecast:

Buy
90%
Hold
10%

Financial data from Celltrion

Jun '26
+/-
%
4,897,805 4,897,805
31% 31%
100%
- Direct Costs 1,867,927 1,867,927
6% 6%
38%
3,029,878 3,029,878
52% 52%
62%
- Selling and Administrative Expenses 1,170,185 1,170,185
28% 28%
24%
- Research and Development Expense 233,837 233,837
8% 8%
5%
1,625,856 1,625,856
88% 88%
33%
- Depreciation and Amortization 75,611 75,611
13% 13%
2%
EBIT (Operating Income) EBIT 1,550,245 1,550,245
95% 95%
32%
Net Profit 1,576,119 1,576,119
220% 220%
32%

In millions KRW.

Don't miss a Thing! We will send you all news about Celltrion directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Celltrion, Inc. engages in the development, manufacture and distribution of pharmaceuticals. It operates through the Biopharmaceuticals, Chemical Drugs and Others businesses. Its products include remsima and biosimilars. The company was founded on February 27, 1991 and is headquartered in Incheon, South Korea.

Head office South Korea
CEO Mr. Gi
Employees 2,680
Founded 1991
Website www.celltrion.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today